Recruiting at 1 site No phase Morbid Obesity

Morbid Obesity study: Surgery

Official title Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)

ClinicalTrials.gov ID: NCT06293703

What this study is testing

What it's testing
This study aims to find out if adjusting the surgery size based on a person's body leads to more weight loss and better control of health issues like diabetes and high blood pressure.
Who it's for
The study is looking for people with severe obesity who are scheduled to have weight-loss surgery.
What's involved
Participants will have weight-loss surgery where the new tube length is calculated based on their total intestine length, rather than using a standard fixed size.
Time commitment
The source text does not specify the total duration of the study or the number of required visits.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 70

You may be able to join if

  • morbidly obese patients (defined by BMI between 40 and 60).
  • Patient who understands and accepts the need for a long-term follow-up.
  • Patient who agrees to be included in the study

You likely can't join if

  • individuals unable to understand and sign a written consent form
  • patients with history of previous bariatric surgery procedures
  • presence of a severe and evolutive life threatening pathology unrelated to obesity
  • previous gastric or small bowel resection
  • active cancer
  • pregnancy or desired to be pregnant during the study
See the full eligibility criteria
Who can join
  • morbidly obese patients (defined by BMI between 40 and 60).
  • Patient who understands and accepts the need for a long-term follow-up.
  • Patient who agrees to be included in the study
What rules you out
  • individuals unable to understand and sign a written consent form
  • patients with history of previous bariatric surgery procedures
  • presence of a severe and evolutive life threatening pathology unrelated to obesity
  • previous gastric or small bowel resection
  • active cancer
  • pregnancy or desired to be pregnant during the study
  • mentally unbalanced patients under supervision or guardianship, patient unable to give consent

The study team makes the final eligibility decision.

Where it is enrolling

  • Cleveland, Ohio, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Cleveland, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.